With several countries supporting trials of the drug and the company being here, in Europe and else where a more equitable approach for those most in need would have been possible and likely had it not been for a certain **** you attitude in the US now.
The company is reliably reported to having its arm twisted in a big way to do it this way. Noting they kindly have involved 2 generic manufactures to try and help India and Pakistan. It would have been easy for them to also add capacity via other manufactures in every country which might happen anyway.
UK Doc nails it
"It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights," Dr Yaqub said in a statement.

